Covered recipient · General Payments record
KENNETH M MINETT
Allopathic & Osteopathic Physicians Emergency Medicine
General Payments · PY2019–2024
$544,288.61
- Reported across 215 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $184,607.22 | 55 |
| Food and Beverage | $107.50 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $184,607.22 | 55 |
| Acerta Pharma LLC | $107.50 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (56)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $2,092.32 | 01/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105042056 | CMS |
| ABBVIE INC. | $2,876.94 | 01/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105042058 | CMS |
| ABBVIE INC. | $523.08 | 01/19/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105042060 | CMS |
| ABBVIE INC. | $3,138.48 | 01/26/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105042062 | CMS |
| ABBVIE INC. | $1,830.78 | 02/06/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105042064 | CMS |
| ABBVIE INC. | $2,353.86 | 02/14/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105042066 | CMS |
| ABBVIE INC. | $1,830.78 | 02/23/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105042068 | CMS |
| ABBVIE INC. | $1,046.16 | 02/27/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105042070 | CMS |
| ABBVIE INC. | $1,569.24 | 03/04/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105042072 | CMS |
| ABBVIE INC. | $2,746.17 | 03/08/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105042074 | CMS |
| ABBVIE INC. | $2,484.63 | 03/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105042076 | CMS |
| ABBVIE INC. | $2,615.40 | 03/25/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105042078 | CMS |
| ABBVIE INC. | $2,615.40 | 03/29/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105042080 | CMS |
| ABBVIE INC. | $2,680.79 | 04/08/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105042082 | CMS |
| ABBVIE INC. | $8,107.74 | 04/16/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105042084 | CMS |
| ABBVIE INC. | $3,661.56 | 04/19/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105042086 | CMS |
| ABBVIE INC. | $3,269.25 | 04/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105042088 | CMS |
| ABBVIE INC. | $3,269.25 | 05/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105042090 | CMS |
| ABBVIE INC. | $3,269.25 | 05/04/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105042092 | CMS |
| ABBVIE INC. | $3,400.02 | 05/14/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105042094 | CMS |
| ABBVIE INC. | $3,400.02 | 05/17/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105042096 | CMS |
| ABBVIE INC. | $2,746.17 | 05/28/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105042098 | CMS |
| ABBVIE INC. | $6,342.35 | 06/12/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105042100 | CMS |
| ABBVIE INC. | $3,138.48 | 06/12/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105042102 | CMS |
| ABBVIE INC. | $4,642.34 | 06/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105042104 | CMS |
| ABBVIE INC. | $1,438.47 | 06/21/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105042106 | CMS |
| ABBVIE INC. | $4,066.66 | 07/12/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105042108 | CMS |
| ABBVIE INC. | $2,502.56 | 07/12/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105042110 | CMS |
| ABBVIE INC. | $2,502.56 | 07/21/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105042112 | CMS |
| ABBVIE INC. | $2,502.56 | 07/21/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105042114 | CMS |
| ABBVIE INC. | $3,441.02 | 07/21/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105042116 | CMS |
| ABBVIE INC. | $2,502.56 | 07/21/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105042118 | CMS |
| ABBVIE INC. | $2,502.56 | 07/21/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105042120 | CMS |
| ABBVIE INC. | $1,876.92 | 07/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105042122 | CMS |
| ABBVIE INC. | $1,307.70 | 08/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105042124 | CMS |
| ABBVIE INC. | $5,100.03 | 08/13/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105042126 | CMS |
| ABBVIE INC. | $5,426.96 | 08/21/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105042128 | CMS |
| ABBVIE INC. | $2,484.63 | 08/26/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105042130 | CMS |
| ABBVIE INC. | $3,923.10 | 09/03/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105042132 | CMS |
| ABBVIE INC. | $4,576.95 | 09/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105042134 | CMS |
| ABBVIE INC. | $5,361.57 | 09/13/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105042136 | CMS |
| ABBVIE INC. | $5,361.57 | 09/23/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105042138 | CMS |
| ABBVIE INC. | $4,707.72 | 09/26/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105042140 | CMS |
| ABBVIE INC. | $2,502.56 | 10/16/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105042142 | CMS |
| ABBVIE INC. | $2,502.56 | 10/16/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105042144 | CMS |
| ABBVIE INC. | $3,441.02 | 10/31/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105042146 | CMS |
| ABBVIE INC. | $2,189.74 | 10/31/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105042148 | CMS |
| ABBVIE INC. | $4,903.88 | 11/04/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105042150 | CMS |
| ABBVIE INC. | $5,230.80 | 11/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105042152 | CMS |
| ABBVIE INC. | $7,192.35 | 11/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105042154 | CMS |
| ABBVIE INC. | $7,323.12 | 11/25/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105042156 | CMS |
| ABBVIE INC. | $4,576.95 | 11/27/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105042158 | CMS |
| ABBVIE INC. | $2,502.56 | 12/06/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105042160 | CMS |
| ABBVIE INC. | $2,502.56 | 12/06/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105042162 | CMS |
| ABBVIE INC. | $2,502.56 | 12/10/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105042164 | CMS |
| AstraZeneca Pharmaceuticals LP | $107.50 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104508592 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.